Press Releases

Please click here if you wish to receive an e-mail notification regarding Alector press releases.

Oct 07, 2026

Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled Pipeline

Oct 05, 2026

Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases

Sep 03, 2026

Alector to Participate in Upcoming Healthcare Conferences

Aug 06, 2026

Alector Reports Second Quarter 2026 Financial Results and Provides Business Update

May 07, 2026

Alector Reports First Quarter 2026 Financial Results and Provides Business Update

Apr 29, 2026

Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer’s Disease Following Interim Futility Analysis

Feb 25, 2026

Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Feb 24, 2026

Alector to Participate in the TD Cowen 46th Annual Health Care Conference

Close

Are you sure you want to leave?

You are about to leave the Alector site. Please note our privacy policy won’t apply to these third-party sites.

Continue
Cancel